These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8863874)

  • 1. Chronic diarrhoea as a dominating symptom in two children with cerebrotendinous xanthomatosis.
    van Heijst AF; Wevers RA; Tangerman A; Cruysberg JR; Renier WO; Tolboom JJ
    Acta Paediatr; 1996 Aug; 85(8):932-6. PubMed ID: 8863874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.
    DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB
    J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.
    Batta AK; Salen G; Tint GS
    Metabolism; 2004 May; 53(5):556-62. PubMed ID: 15131757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and follow-up of children with cerebrotendinous xanthomatosis.
    van Heijst AF; Verrips A; Wevers RA; Cruysberg JR; Renier WO; Tolboom JJ
    Eur J Pediatr; 1998 Apr; 157(4):313-6. PubMed ID: 9578968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of urinary bile alcohol excretion and serum cholestanol in patients with cerebrotendinous xanthomatosis after oral administration of deoxycholic acid.
    Wolthers BG; van der Molen JC; Walrecht H; Hesselmans LF
    Clin Chim Acta; 1990 Dec; 193(3):113-8. PubMed ID: 2282689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K
    Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat.
    Berginer VM; Gross B; Morad K; Kfir N; Morkos S; Aaref S; Falik-Zaccai TC
    Pediatrics; 2009 Jan; 123(1):143-7. PubMed ID: 19117873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
    Wolthers BG; Volmer M; van der Molen J; Koopman BJ; de Jager AE; Waterreus RJ
    Clin Chim Acta; 1983 Jun; 131(1-2):53-65. PubMed ID: 6883710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment.
    Martini G; Mignarri A; Ruvio M; Valenti R; Franci B; Del Puppo M; Federico A; Nuti R; Dotti MT
    Calcif Tissue Int; 2013 Mar; 92(3):282-6. PubMed ID: 23212544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.
    Verrips A; van Engelen BG; Wevers RA; van Geel BM; Cruysberg JR; van den Heuvel LP; Keyser A; Gabreëls FJ
    Arch Neurol; 2000 Apr; 57(4):520-4. PubMed ID: 10768627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment.
    Huidekoper HH; Vaz FM; Verrips A; Bosch AM
    Eur J Pediatr; 2016 Jan; 175(1):143-6. PubMed ID: 26156051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis.
    Salen G; Batta AK; Tint GS; Shefer S
    Metabolism; 1994 Aug; 43(8):1018-22. PubMed ID: 8052141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebrotendinous xanthomatosis].
    Verrips A
    Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1673-7. PubMed ID: 11561482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.
    Catarino CB; Vollmar C; Küpper C; Seelos K; Gallenmüller C; Bartkiewicz J; Biskup S; Hörtnagel K; Klopstock T
    J Neurol; 2018 Feb; 265(2):388-393. PubMed ID: 29260356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
    Batta AK; Shefer S; Batta M; Salen G
    J Lipid Res; 1985 Jun; 26(6):690-8. PubMed ID: 4031647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
    Kimura S; Beppu T; Kugai N; Koide Y; Fujita T; Iida K; Yamashita N; Yamashita K; Seyama Y
    Jpn J Med; 1982 Jul; 21(3):210-5. PubMed ID: 7143816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
    Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
    J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.